Karonudib is a promising anticancer therapy in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the most common form of liver cancer and is generally caused by viral infections or consumption of mutagens, such as alcohol. While liver transplantation and hepatectomy is curative for some patients, many relapse into disease with few treatment options...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Xiangwei, Sanjiv, Kumar, Gad, Helge, Pham, Therese, Gokturk, Camilla, Rasti, Azita, Zhao, Zhenjun, He, Kang, Feng, Mingxuan, Zang, Yunjin, Zhang, Jianjun, Xia, Qiang, Helleday, Thomas, Warpman Berglund, Ulrika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710815/
https://www.ncbi.nlm.nih.gov/pubmed/31489034
http://dx.doi.org/10.1177/1758835919866960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710815/
https://www.ncbi.nlm.nih.gov/pubmed/31489034
http://dx.doi.org/10.1177/1758835919866960

Ejemplares similares